Normal pregnancy in a patient with β-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade®)
Authors:
Open Access
- 25 January 2011
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 86 (3) , 274-275
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Iron Studies in Infants Born to an Iron Overloaded Mother With β-Thalassemia Major: Possible Effects of Maternal Desferrioxamine TherapyJournal of Pediatric Hematology/Oncology, 2007
- PREGNANCY IN PATIENTS TREATED FOR BETA THALASSEMIA MAJOR IN TWO CENTERS (ALI ASGHAR CHILDREN'S HOSPITAL AND THALASSEMIA CLINIC): Outcome for Mothers and Newborn InfantsPediatric Hematology and Oncology, 2006
- Complications of β-thalassemia major in North AmericaBlood, 2004
- Reproductive Health in Female Patients with β‐Thalassemia MajorAnnals of the New York Academy of Sciences, 2000
- Deferoxamine treatment during pregnancy: Is it harmful?American Journal of Hematology, 1999
- Fertility in female patients with thalassemia.1998
- Fertility in thalassemia: the Greek experience.1998
- Transfusion-dependent homozygous β-thalassaemia major: successful pregnancy in five casesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1997
- Fertility in β thalassaemia major: a report of 16 pregnancies, preconceptual evaluation and a review of the literatureBJOG: An International Journal of Obstetrics & Gynaecology, 1995
- Deferoxamine treatment during early pregnancy: absence of teratogenicity in two cases.1993